A 24-year-old woman presents to the clinic with a 3-month history of profound fatigue, symmetric arthralgias in her hands and wrists, and an erythematous rash over her cheeks that worsens after sun exposure. Physical examination reveals synovitis in the metacarpophalangeal joints bilaterally and a malar rash sparing the nasolabial folds. Arrange the following steps in the most appropriate chronological sequence for her diagnostic evaluation and longitudinal management.
- 1Perform an antinuclear antibody (ANA) assay to evaluate for an autoimmune etiology.
- 2Obtain anti-double-stranded DNA (anti-dsDNA) and anti-Smith antibodies for diagnostic confirmation.
- 3Initiate disease-modifying therapy with oral hydroxychloroquine.
- 4Complete a baseline dilated ophthalmologic examination to monitor for potential drug toxicity.
Cevap
The correct sequence is: 1) Perform an antinuclear antibody (ANA) assay, 2) Obtain anti-dsDNA and anti-Smith antibodies, 3) Initiate disease-modifying therapy with oral hydroxychloroquine, and 4) Complete a baseline dilated ophthalmologic examination.
The evaluation and management of suspected systemic lupus erythematosus (SLE) follows a sequential approach to maximize diagnostic accuracy and therapeutic safety. The first step is to perform an antinuclear antibody (ANA) assay. ANA is highly sensitive for SLE, making it an excellent initial screening tool; a negative result makes SLE highly unlikely. If the ANA is positive, the next step is to order highly specific tests, such as anti-double-stranded DNA (anti-dsDNA) and anti-Smith antibodies, to definitively confirm the diagnosis, as ANA can be positive in healthy individuals or in other autoimmune conditions. Once the diagnosis is confirmed, hydroxychloroquine is the cornerstone of therapy and should be initiated promptly for all patients (unless contraindicated) to reduce disease flares, organ damage, and overall mortality. Finally, because hydroxychloroquine is associated with a dose- and time-dependent risk of irreversible retinal toxicity (maculopathy), patients require a baseline formal ophthalmologic evaluation (typically within the first year of treatment) to establish a reference for future, long-term retinal screening.
Adım Adım Çözüm
Anahtar Kavram
The step-wise approach to systemic lupus erythematosus involves highly sensitive screening (ANA), highly specific confirmation (anti-dsDNA/anti-Smith), foundational therapy (hydroxychloroquine), and subsequent toxicity monitoring (baseline ophthalmologic exam).